Treatment
Treatment clinical trials
We’re tracking 8,479 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07036380RecruitingPhase 2
Testing MP0317 with chemotherapy for advanced bile duct cancer
This trial tests if adding a new drug (MP0317) to standard chemoimmunotherapy helps people with advanced bile duct cancer. It's for patients who haven't had treatment yet, except for certain past adjuvant therapy.
BesançonAges 18 years+ - NCT07036523RecruitingPhase 2
Study of BI 765423 for Idiopathic Pulmonary Fibrosis (IPF)
This trial tests a new drug, BI 765423, to see if it improves lung function in people with IPF. You can join if you are 40 or older, have a confirmed IPF diagnosis, and meet certain lung function criteria, whether or not you are currently on standard treatments like nintedanib or pirfenidone.
Birmingham, AlabamaAges 40 years+ - NCT07036705Recruiting
Sauna blanket and app for better sleep in insomnia
This study tests whether using a heated sauna blanket before bed, along with a mind-body app, can help adults with insomnia fall asleep faster and sleep better. You would use the blanket at home for a few weeks and answer questions about your sleep.
San Francisco, CaliforniaAges 18 years+ - NCT07036848Recruiting
Surgery for type IVa bile duct cyst
This study tests how well and safely a surgery works for treating a certain type of bile duct cyst (Todani type IVa). It aims to improve outcomes for people who need this operation for the first time.
Beijing, Beijing MunicipalityAges Up to 80 years - NCT07037004RecruitingPhase 2
Testing a gut health supplement with immunotherapy after kidney cancer surgery
This trial is testing whether adding a gut health supplement (CBM588) to the immunotherapy drug pembrolizumab can help prevent kidney cancer from returning after surgery. It is for people with certain types of kidney cancer who have not had immunotherapy before.
Duarte, CaliforniaAges 18 years+ - NCT07037238RecruitingPhase 2
Everolimus for treating vascular malformations
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
BeijingAges 18–65 - NCT07038265Recruiting
Personalized cardiac rehab after a heart attack
This study tests a personalized cardiac rehabilitation program for people who have recently had a heart attack. The program is designed to be more patient-centered, helping you recover and lower your risk for future heart problems.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT07038356RecruitingPhase 3
Continuing empagliflozin for heart failure patients in hospital
This trial tests whether staying on the medication empagliflozin helps people with heart failure who are hospitalized for worsening symptoms. Empagliflozin is a type of drug called an SGLT2 inhibitor, which helps control blood sugar and protect the heart.
Jena, ThuringiaAges 18 years+ - NCT07038811Recruiting
App for treating urgent or mixed urinary incontinence
This trial tests a smartphone app called Tät®II to help women with urgency or mixed urinary incontinence. The app may provide exercises and strategies to reduce symptoms without medication or surgery.
ÖstersundAges 18 years+ - NCT07038928Recruiting
Treatment patterns and markers in bladder cancer in Russia
This study looks at how bladder cancer is treated and what biological markers are present in patients in Russia. If you join, you may help doctors learn more about which treatments work best based on your tumor type.
ArkhangelskAges 18 years+ - NCT07039370Recruiting
TMS for depression: looking for brain signals of response
This trial tests if brain scans or electrical signals can predict who will get better with TMS (transcranial magnetic stimulation) for depression. It is for people whose depression did not improve after trying two or more antidepressants.
Ankara, AnkaraAges 18–65 - NCT07039578RecruitingPhase 2
Study of CM336 for light-chain amyloidosis
This trial tests a new injection called CM336 for people with light-chain amyloidosis that has come back or not responded to other treatments. It aims to see if the drug is safe and effective.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07039604Recruiting
Real-world study of PADN for pulmonary artery hypertension
This study tracks how well a procedure called PADN works for people with pulmonary artery hypertension (PAH) in real-life medical settings. PADN is a minimally invasive treatment that targets nerves around the lungs to help lower blood pressure in the arteries.
Nanjing, JiangsuAges Any age - NCT07040072RecruitingPhase 1
Finotonlimab plus Stapokibart for advanced head and neck cancer
This trial tests two drugs, Finotonlimab and Stapokibart, for people with head and neck cancer that has come back or spread to other parts of the body. It may help if you've already tried a PD-1 drug and platinum chemotherapy, but the cancer got worse.
Beijing, Beijing MunicipalityAges 18–75 - NCT07040228RecruitingPhase 1/Phase 2
Study of regorafenib, toripalimab, and chemo for advanced pancreatic cancer
This trial tests a combination of three drugs (regorafenib, toripalimab, and albumin-bound paclitaxel) as a third-line treatment for advanced pancreatic cancer that has progressed after two prior therapies. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Shenzhen, GuangdongAges 18–80 - NCT07040397Recruiting
Massage therapy study for lower back pain
This study tests whether an electronic approach to massage therapy can help relieve lower back pain. It may be an option if you have persistent lower back pain and haven't used pain medications recently.
Rochester, MinnesotaAges 18 years+ - NCT07040982RecruitingPhase 1
Asciminib after cell therapy for Ph+ ALL
This trial tests the drug asciminib after a stem cell transplant or CAR T-cell therapy for adults with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) to help prevent the cancer from coming back.
Duarte, CaliforniaAges 18 years+ - NCT07041723Recruiting
Online biofeedback for
This study tests an online biofeedback program to help children and teens improve their 's' and 'z' sounds. It might be a good fit if your child struggles with these sounds and meets a few other health and age guidelines.
Bloomfield, New JerseyAges 8–17 - NCT07042165RecruitingPhase 4
Atorvastatin for Bile Acid Diarrhea
This trial tests whether the statin atorvastatin can reduce diarrhea in people with moderate to severe bile acid diarrhea. You’ll take either atorvastatin or a placebo (no active drug) for a set period while tracking your bowel habits.
HellerupAges 18 years+ - NCT07042191Recruiting
Talking about treatment costs to reduce financial stress
This trial works with doctors, nurses, and social workers to help them talk to patients about the costs of cancer treatment. The goal is to see if better conversations about money can lower financial worry for people with cancer.
Detroit, MichiganAges Any age - NCT07042451Recruiting
Testing a phone app to support recovery after substance use treatment
This trial is testing whether a smartphone app called Pink Cloud can help people stay in recovery after finishing substance use treatment. You would need to attend one recovery meeting in the next week and use the app on your personal phone.
Los Angeles, CaliforniaAges 18 years+ - NCT07042919RecruitingPhase 1/Phase 2
Zanzalintinib for advanced liver cancer after prior treatment
This trial tests a new drug called zanzalintinib for people with advanced liver cancer (HCC) that can't be treated with surgery. You may join if your cancer has gotten worse after at least one prior treatment, or you couldn't tolerate that treatment.
Chicago, IllinoisAges 18 years+ - NCT07043725RecruitingPhase 3
Neoadjuvant TQB2102 for HER2-positive breast cancer
This trial tests a new drug called TQB2102 given before surgery for HER2-positive breast cancer. The goal is to see if it can shrink the tumor enough to allow a successful surgery.
Bengbu, AnhuiAges 18–75 - NCT07044830Recruiting
Sleep apnea treatment for stroke recovery
This trial tests whether treating sleep apnea with a CPAP machine soon after a stroke can improve recovery. It is for people who had their first moderate-to-severe ischemic stroke and have not used CPAP before.
Ribeirão Preto, São PauloAges 18–80
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,479 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.